Literature DB >> 22291880

White matter correlates of neuropsychological dysfunction in systemic lupus erythematosus.

Rex E Jung1, Robert S Chavez, Ranee A Flores, Clifford Qualls, Wilmer L Sibbitt, Carlos A Roldan.   

Abstract

Patients diagnosed with Systemic Lupus Erythematosus have similar levels of neuropsychological dysfunction (i.e., 20-50%) as those with Neuropsychiatric Systemic Lupus Erythematosus (NPSLE). We hypothesized a gradient between cognition and white matter integrity, such that strongest brain-behavior relationships would emerge in NPSLE, intermediate in non-NPSLE, and minimal in controls. We studied thirty-one patients (16 non-NPSLE; 15 NPSLE), ranging in age from 18 to 59 years old (100% female), and eighteen age and gender matched healthy controls. DTI examinations were performed on a 1.5T scanner. A broad neuropsychological battery was administered, tapping attention, memory, processing speed, and executive functioning. The Total z-score consisted of the combined sum of all neuropsychological measures. In control subjects, we found no significant FA-Total z-score correlations. NPSLE, non-NPSLE, and control subjects differed significantly in terms of Total z-score (NPSLE = -2.25+/-1.77, non-NPSLE = -1.22+/-1.03, Controls = -0.10+/-.57; F = 13.2, p<.001). In non-NPSLE subjects, FA within the right external capsule was significantly correlated with Total z-score. In NPSLE subjects, the largest FA-Total z-score clusters were observed within the left anterior thalamic radiation and right superior longitudinal fasciculus. In subsequent analyses the largest number of significant voxels linked FA with the Processing Speed z-score in NPSLE. The current results reflect objective white matter correlates of neuropsychological dysfunction in both NPSLE and (to a lesser degree) in non-NPSLE. non-NPSLE and NPSLE subjects did not differ significantly in terms of depression, as measured by the GDI; thus, previous hypotheses suggesting moderating effects of depression upon neuropsychological performance do not impact the current FA results.

Entities:  

Mesh:

Year:  2012        PMID: 22291880      PMCID: PMC3266882          DOI: 10.1371/journal.pone.0028373

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Cognitive dysfunction is a significant (i.e., 20–42%) comorbid characteristic of systemic lupus erythematosus [1]. However, SLE patients with significant neurological involvement – collectively known as neuropsychiatric systemic lupus erythematosus (NPSLE) – have comparable levels of cognitive dysfunction (27–52%) [2]. NPSLE has been hypothesized to have multiple causal etiologies, many of which are hypothesized to affect white matter functioning, including: inflammatory, hypoperfusion, thrombotic, vasculitic, atherosclerotic, and/or cardioembolic, further exacerbated by antibody, cytokine, and cytotoxic mediators [3], [4], [5], [6]. Few prospective studies have linked cognitive decline to white matter changes across NPSLE and SLE patient cohorts. In SLE subjects (here forward “non NPSLE”), subtle correlations between neuropsychological measures and white matter integrity, measured by diffusion tensor imaging (DTI), have been observed [7]. The current research is conducted in the identical cohort reported on previously [8], and is therefore post hoc.” Based on previous research [8], [9], [10], [11], [12], we anticipate a gradient between cognition and white matter integrity, such that strongest brain-behavior relationships would emerge in NPSLE, intermediate in non-NPSLE, and minimal in controls.

Methods

Sample

Written informed consent was obtained from all subjects prior to participation in the experimental protocol. The study was approved by the institutional review board of the University of New Mexico, and consistent with the Declaration of Helsinki. Thirty-one female patients were recruited from the Rheumatology Clinics of the University of New Mexico, and ranged in age from 18 to 59 years old. All subjects were diagnosed with lupus based on the 1997 American College of Rheumatology Revised Criteria. The SLE Disease Activity Index (SLEDAI) was used to assess current disease activity [13]. The Systemic Lupus International Collaborative Clinics (SLICC) Damage Index was used to assess accumulated damage due to various organs [14]. Patients with SLE were enrolled prospectively as encountered in either University outpatient or inpatient settings, without regard of SLE disease activity and severity. No patients were scanned or tested in the presence of active neuropsychiatric symptoms (e.g., acute confusional state, psychosis), although most had some level of chronic cognitive dysfunction. No non-NPSLE patient complained of cognitive dysfunction, thus they remained categorized under ACR guidelines as SLE. All assessments (clinical, behavioral, imaging) were conducted within one month following onset of neuropsychiatric events. Sixteen patients met the American College of Rheumatology case definitions for Neuropsychiatric (NP) events in SLE, defined as acute stroke or transient ischemic attack (TIA), acute confusional state, moderate cognitive dysfunction, seizures, or psychosis [15]. Fifteen patients had non-NPSLE, but met criteria for Systemic Lupus Erythematosus. Patients were compared to eighteen female, age matched, healthy controls. The SLE Disease Activity Index (SLEDAI) was used to assess current disease activity across nine organ systems including: central nervous system, vascular, renal, musculoskeletal, serosal, dermal, immunologic, constitutional, and hematologic [13]. Forty-nine (of fifty-three) subjects were reported in a previous study showing DTI differences between NPSLE and non-NPSLE patients [8]; therefore the design is post hoc. The current sample differs from our previous report in that we focus exclusively on female subjects (previous sample included one male NPSLE patient, one male non NPSLE patient, and two male controls). We encourage readers to review that open access paper for additional information regarding clinical characteristics of patients, lesion load, and statistical comparisons referred to within the current study (http://www.biomedcentral.com/1471-2377/10/65).

Image Acquisition

MR examinations were conducted on a 1.5T scanner using an 8-channel phased array head coil. DTI was acquired as follows: [TE = 92 ms, TR = 10000 ms; FOV = 256 mm; 64 slices; 2 mm slice thickness; 12 diffusion directions; Total acquisition time = 4∶32]. DTI was performed twice and averaged to increase signal to noise ratio.

Behavioral Measure

The neuropsychological battery is in general compliance with the recommendations of the American College of Rheumatology [16]. The Wide Range Achievement Test–3 (WRAT-3) Reading subtest, was used as a measure of premorbid intellectual functioning. Depressive symptoms were assessed with the Geriatric Depression Inventory (GDI). The following tests comprised z-score domains: 1) Trail Making Test Part A, Digit Span–Total Score = Attention z-score; 2) Hopkins Verbal Learning Test–Total Learning Score, Delayed Recall Score = Verbal Memory z-score; 3) Rey Complex Figure Test–Immediate Recall, Delay Recall Scores = Visual Memory z-score; 4) Trail Making Test Part B, Controlled Oral Word Association Test–Total Score, Wisconsin Card Sort–Perseverative Error Score = Executive z-score; 5) Digit Symbol, Symbol Search scores from the Wechsler Adult Intelligence Scale-3 = Processing Speed z-score [17]. The Total z-score consisted of the combined sum of all neuropsychological measures. All subjects individual scores were compared to age matched normative control samples before being summated to z-scores for statistical comparison [18].

Radiological Reads

Brain atrophy and lesions were quantified by one of the authors (WLS), blind to group status of individual scan (NPSLE, non NPSLE, control). Methodology by which lesions loads are quantified in NPSLE cohorts have been described previously by our group [4], [19], [20]. Briefly, MRI scans were classified as “normal” (i.e., no focal abnormalities or diffuse lesions), “abnormal” (i.e., any focal or diffuse abnormality on imaging), or “small focal lesion” (i.e., less than 3 mm in diameter on imaging). Similarly, distinctions were made between “old infarcts” (i.e., hyperintense lesions greater than 3 mm associated with local encephalomalacia and typical changes on T1 images), or “recent infarcts” (i.e., hyperintense lesions associated with restricted diffusion, but without local encephalomalacia. Finally, lesions were localized to subcortical white matter, periventricular white matter, or deep white matter. Fisher's exact test was used to determine statistical group differences between NPSLE and non NPSLE patients across radiological measures (Table 1).
Table 1
ControlsNPSLEnon-NPSLEFp
Demographics, IQ, & Mood
Age 32.238.137.51.310.28
Premorbid IQ (WRAT-3) 4744.9460.400.67
GDI (Depression) 3.912.98.99.30 0.0004
Total z-score −0.1−2.25−1.2213.20 0.001
Fisher's Exact
Medications
Prednisone 15130.33
Cyclophosphamide 640.46
Mycophenalate 221.00
Retuximab 011.00
Hydroxychloroquine 881.00
Aspirin 720.06
Methotrexate 040.10
Coumadin 620.12
Clopidrel 100.48
SSRI 430.69
Anti Seizure 210.60
Narcotics 40 0.04
Depressants 200.23
Pulse Chemotherapy 420.40
Other 011.00
Radiological Findings
Cortical Atrophy 300.23
Subcortical White Matter Lesions 4100.07
Periventricular White Matter Lesions 1040.09
Deep White Matter Lesions 520.20
Old Infarction 51 0.02
Recent Infarction 101.00

Analysis

Tract-Based Spatial Statistics (TBSS) allows measurement of water movement along white matter tracts on a voxel-by-voxel basis across the entire brain [21]. Detailed methods by which we obtained significant FA differences between NPSLE, non-NPSLE, and control subjects are described in our previous paper [8]. For the current post hoc analysis, the fractional anisotropy (FA) image of each subject was normalized to a 1×1×1 mm3 FA template in the Montreal Neurological Institute (MNI) space using the non-linear registration algorithm FNIRT/FSL (www.fmrib.ox.ac.uk/fsl/). We first correlated the Total z score with FA across each subject group (e.g., NPSLE, non NPSLE, controls) using FSL's General Linear Model (GLM) tool (www.fmrib.ox.ac.uk/fsl/fsl/list). Age was entered into the model as a nuisance variable. All results are corrected at p-values<.05 after controlling for family wise error rate. If significant, then subdomain z-scores (e.g., Processing Speed z score) were then correlated with FA for each subject group. The correlation inferences were tested using permutation methods with FSL's Randomise (www.fmrib.ox.ac.uk/fsl/randomise). We ran 5000 two-tailed Monte Carlo permutation tests, (i.e., both positive and negative associations) for each of the correlations between neuropsychological composite measures and FA. [22], [23]

Results

Demographic data

NPSLE, non-NPSLE, and control subjects did not differ significantly in terms of age (NPSLE = 38.1, non-NPSLE = 37.5, Controls = 32.2; F = 1.31, p = .28), and premorbid intellectual functioning (NPSLE = 44.9+/−7.1; non-NPSLE = 46.0+/−8.0; controls = 47.0+/−7.09; F = .40, p = .67). Control subjects differed from both non-NPSLE (t = 2.44, p = .05) and NPSLE (t = 4.28, p = .0003) on the GDI, a measure of depressive symptomatology (NPSLE = 12.9+/−6.1; non-NPSLE = 8.9+/−7.1; controls = 3.9+/−4.8; F = 9.3, p = .0004); however, NPSLE and non-NPSLE scores on the GDI were not significantly different (t = 1.89, p = .12).

Neuropsychological data

One way ANOVA revealed that NPSLE, non-NPSLE, and control subjects differed significantly in terms of Total z-score (NPSLE = −2.25+/−1.77, non-NPSLE = −1.22+/−1.03, Controls = −0.10+/−.57; F = 13.2, p<.001), with post hoc analysis indicating significant NPSLE-non-NPSLE differences on Total z-score (Tukey HSD; Mean difference = 1.03, Standard Error = .42, Significance = .045). The Total z-score represents roughly 1 standard deviation decline (from premorbid estimates) in overall cognitive functioning for the non-NPSLE group, and a 2 standard deviation decline in functioning for the NPSLE group. Only one subdomain z-score (Processing Speed) showed significant NPSLE-non-NPSLE differences (Tukey HSD; Mean difference = 1.47, Standard Error = .47, Significance = .008).

Clinical, laboratory and treatment features

Table 1 summarizes demographic, clinical, medication, and radiological features between NPSLE and non-NPSLE patients. The patient groups differed significantly on measures of disease activity (SLEDAI-Total: t = 2.88, p = .009) and accumulated organ damage (SLICC-Total: t = 3.44, p = .002). However, when neurological components were removed from these measures, NPSLE patients did not differ from non-NPSLE on the SLEDAI (t = 1.04, p = .31); they did differ on the SLICC (t = 2.17, p = .044), although no individual subscores were significantly different between patient groups. Patient groups did not differ in terms of prevalence of any medications being taken, except for narcotics (p = .04), including average mg of prednisone taken per day (NPSLE = 9.69; non-NPSLE = 5.23; t = 1.58, p = .13). Finally, patient groups did not differ in terms of radiological readings, except for evidence of old infarction (p = .02).

FA – Neuropsychological Correlations by group

In control subjects, we found no significant regions in which FA was correlated with Total z-score. In non-NPSLE subjects, FA within the right external capsule was significantly correlated with Total z-score (p = .029)(Figure 1). No subcomponents of the Total z-score were significantly correlated with FA in non-NPSLE. In NPSLE subjects, FA within numerous regions of the white matter were correlated with Total z-score, the largest cluster being within the left anterior thalamic radiation (p = .004) and right superior longitudinal fasciculus (.007
Figure 1

FA-Total z-score relationships in non-NPSLE.

Significant regions (red/yellow) in which non-NPSLE patients had significant correlations between Fractional Anisotropy and Total z-score. Left – coronal view (front to back of head); middle – axial view (top to bottom of head); right – sagittal view (side to side of head). Green represents the center of major white matter tracts which represent the total regions of statistical analyses.

Figure 2

FA-Total z-score relationships in NPSLE.

Significant regions (red/yellow) in which NPSLE patients had significant correlations between FA and Total z-score. Left – coronal view (front to back of head); middle – axial view (top to bottom of head); right – sagittal view (side to side of head). Green represents the center of major white matter tracts which represent the total regions of statistical analyses.

Table 2
Voxelsp-valuesMNIxMNIyMNIzApproximate Tract
Total z-score
4990.004−20331Left Anterior Thalamic Radiation
3910.0064−3716Splenium Corpus Callosum
3310.00736−4422Right Superior Longitudinal Fasciculus
2490.012391016Right Superior Longitudinal Fasciculus
1750.02−19−5211Left arm of Forceps Major
1700.0222623Mid-body Corpus Callosum
1360.031311230Right Anterior Corona Radiata
1050.049192619Right arm of Forceps Minor
Total = 2056
Attention z-score
4120.00717−429Splenium Corpus Callosum
2710.0141822Mid-body Corpus Callosum
2530.01639617Right Superior Longitudinal Fasciculus
1310.049−27−5515Left arm of Forceps Major
Total = 1067
Verbal Memory z-score
1130.031−31−5213Left Inferior Longitudinal Fasciculus
Total = 113
Visual Memory z-score
11560.001−33−5810Left IF-OF
2160.0292115Right arm of Forceps Minor
1770.027−35−5016Left Superior Longitudinal Fasciculus
1470.038−47−320Left Superior Longitudinal Fasciculus
Total = 1696
Executive z-score
3690.01443316Right Superior Longitudinal Fasciculus
2980.018−222813Left Anterior Thalamic Radiation
1630.0436−3823Right Superior Longitudinal Fasciculus
Total = 830
Processing Speed z-score
5850.00541−4023Right Superior Longitudinal Fasciculus
3440.00912−4113Splenium Corpus Callosum
3080.0143612Right Superior Longitudinal Fasciculus
2200.019−242217Left Anterior Thalamic Radiation
1920.0252424Mid-body Corpus Callosum
1800.028−19−5214Left arm of Forceps Major
1490.037−15−3329Splenium Corpus Callosum
1450.038291230Right Anterior Corona Radiata
1430.038−36−5114Left Superior Longitudinal Fasciculus
1320.042192619Right arm of Forceps Minor
1270.044−26431Left Superior Corona Radiata
1200.04613298Genu Corpus Callosum
Total = 2645 Total voxels in skeleton≈77,000 (Smith et al., 2006, NeuroImage)
Figure 3

FA-Processing Speed z-score in NPSLE.

Significant regions (red/yellow) in which NPSLE patients had significant correlations between FA and Processing Speed z-score. Left – coronal view (front to back of head); middle – axial view (top to bottom of head); right – sagittal view (side to side of head). Green represents the center of major white matter tracts which represent the total regions of statistical analyses.

FA-Total z-score relationships in non-NPSLE.

Significant regions (red/yellow) in which non-NPSLE patients had significant correlations between Fractional Anisotropy and Total z-score. Left – coronal view (front to back of head); middle – axial view (top to bottom of head); right – sagittal view (side to side of head). Green represents the center of major white matter tracts which represent the total regions of statistical analyses.

FA-Total z-score relationships in NPSLE.

Significant regions (red/yellow) in which NPSLE patients had significant correlations between FA and Total z-score. Left – coronal view (front to back of head); middle – axial view (top to bottom of head); right – sagittal view (side to side of head). Green represents the center of major white matter tracts which represent the total regions of statistical analyses.

FA-Processing Speed z-score in NPSLE.

Significant regions (red/yellow) in which NPSLE patients had significant correlations between FA and Processing Speed z-score. Left – coronal view (front to back of head); middle – axial view (top to bottom of head); right – sagittal view (side to side of head). Green represents the center of major white matter tracts which represent the total regions of statistical analyses.

Discussion

This is the first study to evaluate neuropsychological and white matter functioning in a well-matched cohort of female NPSLE, non-NPSLE, and control subjects. Importantly, non-NPSLE and NPSLE subjects did not differ significantly in terms of depression, as measured by the GDI; thus, previous hypotheses suggesting moderating effects of depression upon neuropsychological performance [2], [24] do not appear to impact the current FA results. Similarly, FA differences could not be explained by non-neurological group differences in disease activity (SLEDAI), accumulation of disease burden (SLICC), or medication effects. We know of no evidence linking the higher incidence of narcotic medication use to FA abnormalities. Finally, our results correspond well with the first article showing FA differences between non-NPSLE and NPSLE subjects [11]. Not only do our results replicate similar regions of abnormality in the current cohort of NPSLE patients, including thalamus, corpus callosum, and fronto-parietal white matter regions, but link these regional abnormalities to specific neurocognitive deficits. These finding represent preliminary evidence that the neurocognitive effects of NPSLE differ significantly from non-NPSLE even when tightly matched by age, sex, medication use, mood symptoms, and non-neurological disease activity and accumulated disease burden. Moreover, these neurocognitive effects are well correlated with FA changes within white matter regions outside of overt lesions [8]. These FA changes are consistent with postmortem studies showing subtle findings in fatal NPSLE including global ischemic changes, edema, microhemorrhages, glial hyperplasia, diffuse neuronal/axonal loss, and microthromboemboli [4]. The strongest relationship between white matter integrity and neuropsychological domain was observed for the Processing Speed z-score, a measure sensitive to global white matter functioning. This result partially replicates and extends findings from our laboratory [25] and others [7] showing relationships between measures sensitive to white matter functioning and measures of white matter integrity. Neuroimaging of complex cognition has evolved beyond strict localization of function [26] to greater appreciation of a network approach implicating rapid and accurate transfer of information between coordinated brain regions [27]. Lesion or degradation of white matter throughout this network is associated with decline in cognitive functioning across a wide range of tasks [28]. While several of our NPSLE patients experienced acute, local infarction in the past, many of the white matter tracts implicated in the current study, (e.g., superior longitudinal fasciculus, corpus callosum, anterior thalamic radiation) connect both subcortical and cortical association cortices in service of complex neuropsychological performance [29]. Thus, we interpret the current findings as reflecting reorganization of residual cognitive functioning in relatively intact white matter subserving distributed cognitive networks. There are limitations to this approach, including the fact that five of the NPSLE patients had overt lesions due to stroke, which in turn could have led to Wallerian degeneration at least partially responsible for diffuse white matter changes [30]. It is important to distinguish the current findings, which reflect FA-neuropsychological relationships, likely reflecting brain integrity, as opposed to our previous findings in the same cohort wherein FA differences reflected white matter damage. Future research will be necessary to disentangle the complex interaction between white matter lesions, subsequent Wallerian degeneration, and compensatory changes within networks subserving cognitive performance within experimental cohorts comprised of NPSLE and non-NPSLE patients. Future studies with large clinical samples amenable to subgroup comparisons (e.g., with/without stroke) will assist in determining the additional impact of these variables upon neuropsychological functioning and white matter status. Strengths of the current study include: 1) a relatively young cohort, 2) comparison of NPSLE, non-NPSLE, and control cohorts, and 3) simultaneous administration of cognitive, mood, and white matter measures. In summary, the current results reflect objective white matter correlates of neuropsychological dysfunction in well matched samples of female NPSLE and non-NPSLE patients.
  26 in total

1.  Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus.

Authors:  Gerlof P Th Bosma; Tom W J Huizinga; Simon P Mooijaart; Mark A Van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

2.  Tract-based spatial statistics on diffusion tensor imaging in systemic lupus erythematosus reveals localized involvement of white matter tracts.

Authors:  Bart J Emmer; Ilya M Veer; Gerda M Steup-Beekman; Tom W J Huizinga; Jeroen van der Grond; Mark A van Buchem
Journal:  Arthritis Rheum       Date:  2010-12

Review 3.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

4.  Bayesian analysis of neuroimaging data in FSL.

Authors:  Mark W Woolrich; Saad Jbabdi; Brian Patenaude; Michael Chappell; Salima Makni; Timothy Behrens; Christian Beckmann; Mark Jenkinson; Stephen M Smith
Journal:  Neuroimage       Date:  2008-11-13       Impact factor: 6.556

5.  Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery.

Authors:  Elizabeth Kozora; Misoo C Ellison; Sterling West
Journal:  Arthritis Rheum       Date:  2006-08-15

6.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

7.  Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus.

Authors:  Wilmer L Sibbitt; William M Brooks; Mario Kornfeld; Blaine L Hart; Arthur D Bankhurst; Carlos A Roldan
Journal:  Semin Arthritis Rheum       Date:  2009-10-31       Impact factor: 5.532

8.  Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus.

Authors:  Elizabeth Kozora; Misoo C Ellison; Sterling West
Journal:  Arthritis Rheum       Date:  2004-10-15

9.  Prevalence of cognitive impairment in systemic lupus erythematosus.

Authors:  R M Carbotte; S D Denburg; J A Denburg
Journal:  J Nerv Ment Dis       Date:  1986-06       Impact factor: 2.254

10.  Neuropsychiatric Systemic Lupus Erythematosus.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-09       Impact factor: 3.972

View more
  14 in total

1.  White-matter integrity in patients with systemic lupus erythematosus and memory deficits.

Authors:  Diogo G Corrêa; Nicolle Zimmermann; Rafael S Borges; Denis B Pereira; Thomas M Doring; Gustavo Tukamoto; Rochele P Fonseca; Emerson L Gasparetto
Journal:  Neuroradiol J       Date:  2018-08-09

2.  White Matter Microstructural Abnormalities in Type 2 Diabetes Mellitus: A Diffusional Kurtosis Imaging Analysis.

Authors:  Y Xie; Y Zhang; W Qin; S Lu; C Ni; Q Zhang
Journal:  AJNR Am J Neuroradiol       Date:  2016-12-15       Impact factor: 3.825

3.  Correlation of neurocognitive function and brain lesion load on magnetic resonance imaging in systemic lupus erythematosus.

Authors:  Paola C Roldan; Rex E Jung; Wilmer L Sibbitt; Clifford R Qualls; Ranee A Flores; Carlos A Roldan
Journal:  Rheumatol Int       Date:  2018-06-13       Impact factor: 2.631

Review 4.  Cognitive Dysfunction in Systemic Lupus Erythematosus: A Case for Initiating Trials.

Authors:  Nina Kello; Erik Anderson; Betty Diamond
Journal:  Arthritis Rheumatol       Date:  2019-08-07       Impact factor: 10.995

5.  Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites.

Authors:  Ece Ercan; Cesar Magro-Checa; Romain Valabregue; Francesca Branzoli; Emily T Wood; Gerda M Steup-Beekman; Andrew G Webb; Tom W J Huizinga; Mark A van Buchem; Itamar Ronen
Journal:  Brain       Date:  2016-03-11       Impact factor: 13.501

6.  Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.

Authors:  B Cesar; M G Dwyer; J L Shucard; P Polak; N Bergsland; R H B Benedict; B Weinstock-Guttman; D W Shucard; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2015-06-11       Impact factor: 3.825

7.  Relationship between neuropsychological behavior and brain white matter in first-episode psychosis.

Authors:  Andreia V Faria; Jeffrey Crawford; Chenfei Ye; Johnny Hsu; Anshel Kenkare; David Schretlen; Akira Sawa
Journal:  Schizophr Res       Date:  2019-04-13       Impact factor: 4.939

8.  Episodic memory impairment in systemic lupus erythematosus: involvement of thalamic structures.

Authors:  Nicolle Zimmermann; Diogo Goulart Corrêa; Tania Maria Netto; Tadeu Kubo; Denis Batista Pereira; Rochele Paz Fonseca; Emerson Leandro Gasparetto
Journal:  Clin Rheumatol       Date:  2015-01-10       Impact factor: 2.980

Review 9.  Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction.

Authors:  Philip Watson; Justin Storbeck; Paul Mattis; Meggan Mackay
Journal:  Neuropsychol Rev       Date:  2012-08-11       Impact factor: 7.444

10.  Evaluation of white matter integrity in systemic lupus erythematosus by diffusion tensor magnetic resonance imaging: a study using tract-based spatial statistics.

Authors:  Diogo Goulart Corrêa; Nicolle Zimmermann; Denis Batista Pereira; Thomas M Doring; Tania Maria Netto; Nina Ventura; Rochele Paz Fonseca; Emerson Leandro Gasparetto
Journal:  Neuroradiology       Date:  2016-04-25       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.